Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma

Hayriye V Erkizan1, Vladimir N Uversky, Jeffrey A Toretsky

  • 1Department of Oncology and Pediatrics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

Insights

Targeted cancer therapy is a gold standard. This review explores the EWS-FLI1 fusion protein in Ewing's sarcoma, detailing its interactions and therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Targeted cancer therapy aims to attack tumors with minimal harm to healthy cells.
  • Ewing's sarcoma is characterized by the EWS-FLI1 fusion protein, arising from a specific chromosomal translocation.
  • The EWS-FLI1 protein combines a transcriptional activator (EWS) with a DNA-binding domain (FLI1), leading to cellular transformation.

Purpose of the Study:

  • To review known protein partners and transcriptional targets of the EWS-FLI1 fusion protein.
  • To propose strategies for developing targeted therapies against Ewing's sarcoma by exploiting EWS-FLI1 interactions.

Main Methods:

  • Literature review of studies on EWS-FLI1 protein-protein interactions.
  • Analysis of pathways regulated by EWS-FLI1 partnerships.
  • Identification of potential therapeutic targets based on these interactions.

Main Results:

  • The EWS-FLI1 fusion protein acts as an aberrant transcription factor by interacting with normal cellular proteins.
  • These interactions disrupt normal cellular machinery, contributing to oncogenesis.
  • Specific protein partners and regulated pathways have been identified.

Conclusions:

  • Understanding EWS-FLI1 protein interactions is crucial for comprehending Ewing's sarcoma development.
  • Targeting these specific interactions offers a promising strategy for novel therapeutic interventions.
  • Further research into EWS-FLI1 partnerships can guide the development of effective Ewing's sarcoma treatments.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...